Market Tracker

03/22 5:16pm ET

Incyte Corp (NASDAQ:INCY)

141.28
Delayed Data
As of 4:00pm ET
 +0.55 / +0.39%
Today’s Change
65.50
Today|||52-Week Range
153.15
+40.90%
Year-to-Date

Today’s Trading

Previous close140.73
Today’s open141.84
Day’s range140.01 - 143.58
Volume3,860,295
Average volume (3 months)2,099,985
Market cap$28.7B
Dividend yield--
Data as of 4:00pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-39.39%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+46.70%
P/E ratio261.6
Price/Sales17.60
Price/Book63.36

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.39+0.76%
ALXNAlexion Pharmaceutic...+1.38+1.16%
ZTSZoetis Inc+0.48+0.90%
MYLMylan NV+0.03+0.07%
Data as of 4:00pm ET, 03/22/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts